Literature DB >> 11922947

Prediction of 'drug-likeness'.

W Patrick Walters1, Mark A Murcko.   

Abstract

Recent developments in combinatorial chemistry and high-throughput screening have dramatically increased the scale on which drug discovery programs are carried out. Along with these advances has come a need for automated methods of determining which compounds from a library should be synthesized and screened. These methods range from simple counting schemes to sophisticated machine learning techniques such as neural networks. While many of these methods have performed well in validation studies, the field is still in its formative stage. This paper reviews a number of computational techniques for identifying drug-like molecules and examines challenges facing the field.

Mesh:

Year:  2002        PMID: 11922947     DOI: 10.1016/s0169-409x(02)00003-0

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  101 in total

1.  Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers.

Authors:  Aurélien Monge; Alban Arrault; Christophe Marot; Luc Morin-Allory
Journal:  Mol Divers       Date:  2006-09-21       Impact factor: 2.943

2.  Total synthesis, stereochemical assignment, and biological activity of all known (-)-trigonoliimines.

Authors:  Sunkyu Han; Karen C Morrison; Paul J Hergenrother; Mohammad Movassaghi
Journal:  J Org Chem       Date:  2013-10-31       Impact factor: 4.354

3.  An integrated drug-likeness study for bicyclic privileged structures: from physicochemical properties to in vitro ADME properties.

Authors:  Chunyan Han; Jinlan Zhang; Mingyue Zheng; Yao Xiao; Yan Li; Gang Liu
Journal:  Mol Divers       Date:  2011-05-03       Impact factor: 2.943

4.  Discovery of Mer kinase inhibitors by virtual screening using Structural Protein-Ligand Interaction Fingerprints.

Authors:  C Da; M Stashko; C Jayakody; X Wang; W Janzen; S Frye; D Kireev
Journal:  Bioorg Med Chem       Date:  2015-01-13       Impact factor: 3.641

5.  IADE: a system for intelligent automatic design of bioisosteric analogs.

Authors:  Peter Ertl; Richard Lewis
Journal:  J Comput Aided Mol Des       Date:  2012-09-28       Impact factor: 3.686

6.  In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease.

Authors:  Md Rezaul Islam; Aubhishek Zaman; Iffat Jahan; Rajib Chakravorty; Sajib Chakraborty
Journal:  J Young Pharm       Date:  2013-12-15

7.  Identification of adaptive inhibitors of Cryptosporidium parvum fatty acyl-coenzyme A synthetase isoforms by virtual screening.

Authors:  Somdeb Chattopadhyay; Rajani Kanta Mahapatra
Journal:  Parasitol Res       Date:  2019-09-05       Impact factor: 2.289

8.  Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery.

Authors:  Sean Ekins; Robert C Reynolds; Hiyun Kim; Mi-Sun Koo; Marilyn Ekonomidis; Meliza Talaue; Steve D Paget; Lisa K Woolhiser; Anne J Lenaerts; Barry A Bunin; Nancy Connell; Joel S Freundlich
Journal:  Chem Biol       Date:  2013-03-21

Review 9.  QSPR studies on aqueous solubilities of drug-like compounds.

Authors:  Pablo R Duchowicz; Eduardo A Castro
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

10.  A comparative study on the molecular descriptors for predicting drug-likeness of small molecules.

Authors:  Hrishikesh Mishra; Nitya Singh; Tapobrata Lahiri; Krishna Misra
Journal:  Bioinformation       Date:  2009-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.